Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 1
2016 2
2017 2
2018 2
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Normalizing fibromyalgia as a chronic illness.
Clauw DJ, D'Arcy Y, Gebke K, Semel D, Pauer L, Jones KD. Clauw DJ, et al. Among authors: semel d. Postgrad Med. 2018 Jan;130(1):9-18. doi: 10.1080/00325481.2018.1411743. Epub 2017 Dec 19. Postgrad Med. 2018. PMID: 29256764 Review.
An evidence-based review of pregabalin for the treatment of fibromyalgia.
Arnold LM, Choy E, Clauw DJ, Oka H, Whalen E, Semel D, Pauer L, Knapp L. Arnold LM, et al. Among authors: semel d. Curr Med Res Opin. 2018 Aug;34(8):1397-1409. doi: 10.1080/03007995.2018.1450743. Epub 2018 Apr 16. Curr Med Res Opin. 2018. PMID: 29519159 Review.
Gender, age, disease severity, body mass index and diabetes may not affect response to subcutaneous tanezumab in patients with osteoarthritis after 16 weeks of treatment. A subgroup analysis of placebo-controlled trials.
Berenbaum F, Schnitzer T, Kivitz A, Viktrup L, Johnston E, Yang R, Whalen E, Tive L, Semel D. Berenbaum F, et al. Among authors: semel d. Int J Clin Pract. 2021 Dec;75(12):e14975. doi: 10.1111/ijcp.14975. Epub 2021 Oct 21. Int J Clin Pract. 2021. PMID: 34626502 Clinical Trial.
A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy.
Simpson DM, Rice AS, Emir B, Landen J, Semel D, Chew ML, Sporn J. Simpson DM, et al. Among authors: semel d. Pain. 2014 Oct;155(10):1943-54. doi: 10.1016/j.pain.2014.05.027. Epub 2014 Jun 4. Pain. 2014. PMID: 24907403 Clinical Trial.